IL-18 Overexpression Promotes Vascular Inflammation and Remodeling in a Rat Model of Metabolic Syndrome.

Hong-wei Tan,Xu Liu,Xiu-ping Bi,Shan-shan Xing,Li,Hui-ping Gong,Ming Zhong,Zhi-hao Wang,Yun Zhang,Wei Zhang
DOI: https://doi.org/10.1016/j.atherosclerosis.2009.07.053
IF: 5.3
2010-01-01
Atherosclerosis
Abstract:Although considerable evidence implicates the cytokine interlukin-18 (IL-18) in metabolic syndrome (MetS), the direct effect of IL-18 on vascular changes of MetS remains unknown. We investigated the chronic in vivo effect of IL-18 on development of MetS and vascular inflammation and remodeling by overexpressing IL-18 protein in fructose-fed rats (FFR), a model of MetS using intravenous administration of an adenovirus encoding rat IL-18. Increased serum IL-18 and vascular inflammatory response were found in FFR. Overexpression of IL-18 aggravated insulin resistance and enhance vascular inflammation and remodeling, which can be reflected by increased aortic expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and enhanced infiltration of macrophages and increased aortic wall thickness and wall-to-lumen ratio. Interestingly, the levels of interleukin-1 receptor-associated kinase 1 (IRAK1) and the activity of nucleus factor-κB (NF-κB) were also significantly increased. Together, these results indicated that chronic elevated IL-18 levels at a supraphsiological concentration aggravated insulin resistance, enhanced vascular inflammation and remodeling, probably by increasing the level of IRAK1 and the activity of NF-κB. Targeting expression of IL-18 or its specific downstream mediators may retard the progression of MetS and its complications.
What problem does this paper attempt to address?